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ABSTRACT
Purpose: Microbial keratitis (MK), is a frequent cause of sight loss worldwide, particularly in low
and middle-income countries. This study aimed to investigate the risk factors of MK in Uganda.
Methods: Using a nested case control, we recruited healthy community controls for patients
presenting with MK at the two main eye units in Southern Uganda between December 2016 and
March 2018. Controls were individually matched for age, gender and village of the cases on a 1:1
ratio. We collected information on demographics, occupation, HIV and Diabetes Mellitus status. In
STATA version 14.1, multivariable conditional logistic regression was used to generate odds ratios
for risk factors of MK and a likelihood ratio test used to assess statistical significance of
associations.
Results: Two hundred and fifteen case-control pairs were enrolled. The HIV positive patients
among the cases was 9% versus 1% among the controls, p = .0003. Diabetes 7% among the cases
versus 1.4% among the controls, p = .012. Eye trauma was 29% versus 0% among the cases and
controls. In the multivariable model adjusted for age, sex and village, HIV (OR 83.5, 95%CI
2.01–3456, p = .020), Diabetes (OR 9.38, 95% CI 1.48–59.3, p = .017) and a farming occupation
(OR 2.60, 95%CI 1.21–5.57, p = .014) were associated with MK. Compared to a low socio-economic
status, a middle status was less likely to be associated with MK (OR 0.29, 95%CI 0.09–0.89,
p < .0001).
Conclusion: MK was associated with HIV, Diabetes, being poor and farming as the main occupa-
tion. More studies are needed to explore how these factors predispose to MK.
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Background
Microbial keratitis (MK), or infection of the cornea, can
be caused by a range of pathogens. The causative organ-
isms include bacteria, viruses, protozoa (e.g. acantha-
moeba), and fungi (yeasts, moulds and microsporidia).
It is characterised by acute or sub-acute onset of pain,
conjunctival hyperemia and corneal ulceration with
a stromal inflammatory cell infiltrate. MK frequently
leads to sight-loss from dense corneal scarring, or even
loss of the eye, especially when the infection is severe
and/or appropriate treatment is delayed.1
MK in low and middle-income countries (LMIC)
has been described as a “silent epidemic”, which leads
to substantial morbidity, related to blindness and other
consequences such as pain and stigma.2 It is the leading
cause of unilateral blindness after cataract in Tropical
regions and is responsible for about 2 million cases of
monocular blindness per year.3 The World Health
Organization (WHO) estimated (2017) that
1.3 million individuals are bilaterally blind from cor-
neal opacity globally (excluding trachoma and vitamin
A deficiency), accounting for 3.2% of binocular
blindness.4 In Sub-Saharan Africa (SSA), MK is an
important cause of binocular blindness and is respon-
sible for about 15% of monocular blindness (Nigeria
National Survey).5,6 The incidence of MK in South
India was estimated at 113/100,000/year and in Nepal
799/100,000/year.7,8 There is only one older report of
the incidence of MK in SSA from Malawi, which sug-
gested a rate of around 180/100,000/year.9 Rates in
high-income settings are lower.10
There are many potential risk factors that may pre-
dispose a person to developing MK with some risk
factors being more specific to settings (region, income
status and organism) and some being ubiquitous. Risk
factors such as trauma especially with vegetative matter
have been associated with fungal keratitis compared to
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a pre-existing ocular disease for bacterial keratitis.11,12
Injury with mud is strongly linked to Acanthamoeba
keratitis.12 In addition, agricultural work and foreign
body in the eye have been implicated.11,13,14 Risk fac-
tors that are more setting specific include the use of
contact lenses, which affects more people in high-
income countries as opposed to the use of traditional
eye medicines (TEM), which is more of a problem in
Low and Middle-Income Countries (LMIC).9,15–18
Other identified risk factors include age (trauma being
common in the lower age groups versus ocular surface
diseases in older folk), gender (males engaging more in
outdoor activities than females) and poverty (MK
mostly is more prevalent in among the poor).11–13
Diabetes Mellitus (DM) has been the most commonly
reported systemic risk factor, especially following kera-
toplasty or corneal trauma.19–21
In the few studies from SSA on the risk factors for
MK, suggested factors include trauma and use of
TEM.22–24 The other risk factors reported in the litera-
ture are steroid use, severe staphylococcal eyelid infec-
tions and the HIV positive cases.17,22–25 However, all
previous studies from Africa, had a limited extrapola-
tion of outcome due to the lack of controls.
The aim of this study, therefore, was to investigate
the role of multiple risk factors (HIV infection, DM,
farming) which are preventable or modifiable by com-
paring MK cases to disease free community controls,
matched for age, sex and village in Uganda.
Methods
Ethical statement
This study followed the tenets of the Declaration of
Helsinki. It was approved by the London School of
Hygiene & Tropical Medicine Ethics Committee (Ref
10647), Mbarara University Research Ethics Committee
(Ref 10/04-16) and Uganda National Council for
Science and Technology (Ref HS-2303). Written
informed consent in Runyankore, the local language,
was obtained before enrolment. If the patient was
unable to read, the information was read to them, and
they were asked to consent by application of the
thumbprint which was independently witnessed.
Study design and setting
A pair-matched case control study was used with a 1:1
case-to-control ratio. The cases were recruited during
the main cohort study that prospectively enrolled
patients with MK that presented to Ruharo Eye
Centre (REC) and Mbarara University and Referral
Hospital Eye Centre (MURHEC) from
December 2016 to March 2018. MURHEC is
a government owned tertiary eye unit established in
2013. It provides mostly free services and attends to
about 6,000–10,000 patients/year. REC is a church-
based fee-paying tertiary eye hospital founded in the
1960s. Attendance is about 20,000–25,000 patients/year.
Both hospitals are in Mbarara Municipality, South-
Western Region, Uganda, approximately four hours’
drive far from Kampala. The two units are about 5km
apart and work closely. Controls were enrolled in com-
munities where the cases came from.
Study participants
For the purpose of this study microbial keratitis was
defined as the loss of corneal epithelium (of at least
1mm diameter) with underlying stromal infiltrate, asso-
ciated with any or all signs of inflammation (conjunc-
tival injection, anterior chamber inflammatory cells, ±
hypopyon).26 Controls were healthy individuals (with-
out any current eye complaint) matched for gender and
address. For cases and controls, we excluded those not
willing to participate, those not willing to return for
follow-up, pregnant women, lactating mothers and
those aged below 18 years.
Sample size
The prevalence of HIV in the general population in
Uganda is 6%. A sample of 200 case-control pairs
would have 80% power and 95% confidence to detect
an odds Ratio of three between cases and controls.
From Tanzanian data we expected that perhaps more
than 10% of MK cases in our cohort would have HIV
infection.17,27
Assessment
Cases
We documented baseline demographic information
and ophthalmic history including how the eye became
infected, predisposing factors such as trauma, prior
use of Traditional Eye Medicine (TEM), treatment
received, and their “health care seeking journey”
before reaching to the eye hospital. In summary,
cases underwent a detailed anterior and posterior seg-
ment examination on a slit lamp. Corneal scrapes were
collected for microscopy, culture and sensitivity and
molecular diagnosis. HIV counselling and testing were
offered, as per the Uganda Ministry of Health HIV
testing protocol where three rapid tests (Determine
HIV-1/2/O [Abbott Laboratories, Abbott Park, IL],
OPHTHALMIC EPIDEMIOLOGY 99
HIV 1/2 Stat-Pak Ultra-Fast [Chembio Diagnostic
Systems, Medford, NY] and Uni-Gold Recombinant
HIV-1/2 [Trinity Biotech, Bray, Ireland]) were used to
screen participants.28 For those who were confirmed
as HIV positive, a CD4 test was performed for level of
immune suppression. They were referred to the HIV
care centre, which is on the hospital site. If a patient
refused the HIV test, they were still enrolled for the
main cohort but were censored for the nested study.
A peripheral prick for blood sugar was taken and
WHO guidelines were used to make a diagnosis of
Diabetes (random glucose >11.1mmol/L or fasting
glucose of >7.0mmol/L).29 Cases were treated empiri-
cally at presentation; the treatment choice was
reviewed after microbiology results according to the
hospital protocol. The study follow-up assessment was
on day 2, day 7, day 21 and at day 90 to determine
their outcome. Additional assessments were con-
ducted as clinically indicated.
Controls
At 3 months, the cases were followed-up in their homes
for a final assessment at which point healthy commu-
nity controls were enrolled. Enrolment followed
a similar method as previously used in Ethiopia.30 The
research team visited the villages (100–200 households),
the local village head was asked to write down all the
eligible controls in that village. They were people of the
same gender and in a similar age bracket (decade) as
the case. One person was randomly selected from this
list using a lottery method, explained to the details of
the study and invited to participate if eligible. If
a selected control refused or was ineligible, another
was randomly selected by lottery. Demographic data
was collected as well as a detailed history of exposure
to trauma, TEM use, DM and HIV status. A random
blood sugar and HIV counselling and testing were
offered, as per the Uganda Ministry of Health HIV
testing protocol. Home testing for HIV is widely prac-
tised in Uganda. For those who were confirmed as HIV
positive, a CD4 test was performed for the level of
immune suppression. They were referred to the nearest
HIV centre for appropriate care. Cases and controls
were asked to self-report their wealth status compared
to their neighbours using a scale of 1 “very poor” 2
“poor” 3 “neither poor nor rich” 4 “rich” 5 “very
rich”.31
Analysis
Data were analysed in STATA v14. All cases and con-
trols were individually matched by age, gender and
village. However, we noticed in the analysis that all
the pairs had not been correctly matched on age
because the village heads had subjectively guessed the
ages of the controls. We thus adjusted for age through-
out the analysis. We compared the proportions of
potential risk factor exposures among cases and control
and performed a Mcnemar’s chi2 test (binary expo-
sures) and a univariable conditional logistic regression
(categorical exposures) for significance of the differ-
ences. The main exposures of interest were HIV posi-
tive patients, DM patients, farmers and participants
with a positive history of trauma and or TEM use.
Multivariable conditional logistic regression analysis
was used to estimate odds ratios (ORs) and 95% CI’s of
risk factors of MK. The likelihood ratio test was used to
assess statistical significance of associations. Variables
with a p-value less than 0.1 were introduced in the
multivariable model. For variables with a high colli-
nearity, the variable of most interest was included in
the model. A backward stepwise approach was then
used until only the variables with a p-value of less
than 0.05 were retained.
Because it was not possible to enrol controls for all
the cases in the cohort, a separate analysis was per-
formed to compare the baseline characteristics of the
cases who had controls and those who did not to look
for any systematic bias. A Pearson Chi test (categorical
variables) or a Wilcoxon rank sum test (continuous
variables) was used to test for significance of the
differences.
Results
A total of 215 controls were enrolled out of 260 eligible
cases who had 3-months outcome data. It was not possi-
ble to enrol controls for 45 cases because of several rea-
sons. These included: not at home at the agreed time of
the home visit (11), wrong home address (4), died (1),
uncooperative village members (20), case address too far
(9). The cases without controls were dropped from the
matched risk factor analysis. We compared the baseline
characteristics and exposure proportions between the
cases for whom we were able to enrol controls versus
the patients without controls (Table 1). Overall, these
two groups were comparable across most of the charac-
teristics. However, there was a significant difference in the
proportion of HIV (22%) among the cases without con-
trols versus the cases with controls (8%), (Chi-square test
10.7, p = .001, df 1). The overall prevalence of HIV was
12% and DMwas 7%. Out of all the 37 HIV positive cases,
14 (38%) were newly diagnosed after presenting withMK.
They were unaware of their current HIV status or had
previously tested negative. The median CD4 count was
358 cells/µL (IQR 267–533, total range 154–1,053). Out of
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the 22 DM patients, 11 (50%) were diagnosed after pre-
senting with MK.
Table 2 shows exposure comparison among the cases
and controls matched for age, sex and village. The
proportion of HIV positive patients among the cases
was 9% versus 1% among the controls (p = .0003). DM
was 7% among the cases versus 1.4% among the con-
trols (p = .012). Sixty-one (29%) of the cases reported
eye trauma before onset of symptoms, none of the
controls reported any trauma in the previous 3 months.
One hundred and twenty-eight (61%) of the cases
reported having used TEM versus only one control
who had recently used TEM. Cases more than controls
had more people in the poor social economic bracket
(p = .0001) and lived further from the nearest village
health centre, median distance 3km (IQR 1–4, total
Table 1. Comparison of people who were enrolled into the nested case-control and those who were not (n = 313).
Enrolled into the case-control (n = 215) Not enrolled (n = 98) ǂ
Variable Median (IQR) (Total range) Median (IQR) (Total range) P value
Age 50 (37–60) (18–96) 42 (33–59) (18–87) .040
Distance 78 (53–120) (1.5–286) 85 (48–183) (0.2–378) .171
Household population 7 (5–8) (1–28) 6 (3–8) (1–18) .030
Distance to nearest Health Centre in KM 3 (1–4) (0–45) 2 (1–4) (0–35) .215
Variable Category count (%) count (%) P value
Gender Female 101 (47) 38 (39) .176
Male 114 (53) 60 (61)
Occupation Farmer 157 (73) 63 (64) .117
Non-farmer 58 (27) 35 (36)
Marital status Not married* 61 (28) 34 (35) .259
Married 154 (72) 64 (65)
Education status None 60 (28) 24 (25) .896
Primary 110 (51) 52 (53)
Secondary 31 (14) 14 (14)
Tertiary 14 (7) 8 (8)
Being head of household Yes 146 (68) 66 (67) .922
No 69 (32) 32 (33)
Being HIV positive (overall 12%) Ɨ Yes 18 (8%) 19 (22%) .001
No 197 (92%) 67 (78%)
Being a Diabetic patient (overall 7%) Ɨ Yes 14 (7%) 8 (9%) .385
No 201 (93%) 77 (91%)
*Not married refers to single, separated, divorced or widowed. Ɨ missing results for HIV and diabetes, it was not possible to test everyone for HIV and
Diabetes. ǂ These 98 include the 53 that were lost to follow up and the 45 cases with follow-up data at 3 months but to whom controls could not be
enrolled.
Table 2. A matched comparison of exposures among 215 case-control pairs. (gender and village and adjusted for age).
Cases (215) Controls (215) P-value
Exposure n (%) n (%)
Married 154 (72) 143 (67) .215
Head of household 146 (68) 140 (65) .441
Education status
None 60 (28) 48 (22) .148
Primary 110 (51) 114 (53)
Secondary 31 (14) 32 (15)
Tertiary 14 (7) 21 (10)
Farming occupation (if yes) 157 (73) 168 (78) .144
Trauma (if yes, n = 214) 63 (29) 0 (0) <.0001
Traditional Eye Medicine (if yes) 133 (62) 1 (0.5) <.0001
HIV (being positive) * 18 (9) 2 (1) .0001
Diabetes Mellitus (being positive) Ɨ 14 (7) 3 (1.4) .012
Size of the household
Small (1–4 people) 50 (23) 109 (51)
Medium (5–10 people) 115 (54) 94 (44)
Large (>11 people) 50 (23) 12 (5)
Self-reported wealth status ǂ
Poor 36 (18) 20 (9) .003
Middle 158 (74) 188 (89)
Upper 21 (8) 6 (2)
Type of water source
Well 103 (50) 107 (52)
Tap 85 (41) 74 (36)
Other 17 (9) 25 (12)
median (IQR) median (IQR)
Distance to nearest Health centre 3 (1–4) 2 (1–3) <.0001
*Twelve cases had missing HIV results, however, all the controls had HIV results reported. Ɨ Nineteen Cases had missing Diabetes test results. self-reported
wealth status was classified as poor (1” very poor” 2” poor”), middle (3 “neither poor nor rich”) upper (4 “rich” 5 “very rich”)
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range 0–45) versus 2km (IQR 1–3, total range 1–15)
among the controls (p < .0001).
Table 3 shows the univariable and multivariable
analysis for risk factors of MK adjusted for age, sex
and village. These were all adjusted for age, sex and
village. In the final model, important risk factors were
HIV (OR 83.5, 95%CI 2.01–3456, p = .020), DM (OR
9.38, 95% CI 1.48–59.3, p = .017), a farming occupation
(OR 2.60, 95%CI 1.21–5.57, p = .014) and living far
from a health facility (OR 1.39, 95%CI 1.14–1.67,
p = .001) were strongly associated with MK. On the
other hand, a middle compared to a low social eco-
nomic status was less associated with MK (OR 0.29,
95%CI 0.09–0.89), p < .0001).
Discussion
This was the first case control study in SSA to investigate
the risk factors of MK. We found that the significant risk
factors were trauma, HIV, DM, farming, living far from
a health facility and poverty.
The odds of being HIV-positive was higher among MK
cases than in the controls, suggesting HIV is a risk factor
for MK. HIV affects the immune system making its host
susceptible to a range of opportunistic infections. Two
previous studies, both from Tanzania, suggested
a possible relationship between HIV and Keratitis.17,25 In
the first study in 1999, the proportion of HIV among MK
cases was 40% with a statistically significant trend towards
fungal Keratitis.25 In the second study in 2003, the propor-
tion of HIV among MK cases was 16%.17 Even though
anti-retroviral therapy (ART) is now widely available in
most parts of SSA, the findings of our study confirmed that
HIV is still an independent risk factor for MK. The pro-
portion ofHIV positive cases in our cohort was 12%, which
was about double the national average of 6.3%.27 In the
group that was considered for the case control analysis, the
proportion ofHIVwasmuch lower among the cases (9% as
opposed to 12%) and controls (1% as opposed to 6%
national average). We speculate that this might have been
due to “healthy user bias” where people who thought they
were HIV negative were more likely to consent as controls.
Although HIV counselling and testing is widely practised
in Uganda, almost 40% of the HIV positive patients in this
study were identified after presenting with MK. They were
unaware their HIV status or previously thought that they
were negative.
We found that the possibility of MK is higher in DM.
Although this had been suggested from other regions, there
have not been any previous studies in SSA that described
this association.32,33 The proportion of DM among theMK
cases was 7%, about thrice the national urban average and
seven times the rural average.34 DM also affects the
immune system making the host susceptible to infection.
Additionally, hyperglycaemia provides essential nutrients
for the pathogens to thrive. This makes treatment more
challenging as these patients tend to respond slowly. The
prevalence of DM is on the rise globally due to lifestyle
changes, In Uganda, there has been a three fold rise over
the last decade.34 We have since started offering routine
HIV and Diabetes screening for all patients presenting
with MK
A farming occupation was another identified risk factor;
our hypothesis is that this was linked to trauma. However,
trauma could not be tested in the model because of none of
the controls reported trauma in the last 3 months. We
found that even among the MK cases, trauma rates were
lower than anticipated (29%). This is consistent with other
studies from sub-Saharan Africa (SSA). In an older study
from Ghana, 39% of MK cases reported some form of eye
injury prior to onset.22 In two separate studies from
Tanzania 24% and 39% of cases were associated with
trauma.17,35 These levels appear to be lower than those
reported from South Asia, where the proportion of MK
Table 3. A matched univariable and multivariable analysis of risk factors of Microbial Keratitis among 215 case-control pairs
(matched for sex, village and adjusted for age).
Univariate Analysis Multivariable Analysis
Variable Crude OR (95% CI) p-value Adjusted OR (95% CI) p-value
Farming occupation (if yes) 2.10 (1.12–3.92) .021 2.60 (1.21–5.57) .014
HIV (being positive) 18.3 (2.41–139) .005 83.5 (2.01–3456) .020
Diabetes Mellitus (being positive) 4.75 (1.29–17.6) .019 9.38 (1.48–59.3) .017
Size of the household*
Small (1–4 people) 1 (reference) <.0001
Medium (5–10 people) 5.09 (2.89–8.94)
Large (>11 people) 1.88 (0.69–5.12)
Social economic status
Poor 1 (reference) <.0001 1 (reference) <.0001
Middle or upper Ɨ 0.21 (0.08–0.56) 0.29 (0.09–0.89)
Upper 1.14 (0.23–5.58) 1.96 (0.34–10.9)
Distance to the nearest Health Centre (increase/km) 1.32 (1.14–1.53) <.0001 1.39 (1.14–1.67) .001
*Family size was highly correlated with wealth status (p = 0.02) and was not included in the model. All analysis was adjusted for age
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cases associated with an injury is typically around
75%.11,36,37 The reason for this difference is not immedi-
ately apparent. Perhaps eye trauma was either not as com-
mon in SSA as SouthAsia or it was too subtle to be recalled.
This might explain why there were even much less recall
among the controls. As one intervention, farmers could be
sensitized and encouraged to use eye protection while
working.
Poverty and health are intricately related. It is linked
to decisions and practises which predisposes indivi-
duals to disease, limit access to care and determine
choices of treatment options (such as use of TEM). In
our study, the odds of MK among individuals of
a “low” economic status were about four times more
than individuals over a “middle” economic status.
According to the latest Uganda household survey,
about 30% of the population is poor.38 This translates
into 12 million who are at an increased risk of MK. In
this study, we noticed that cases were more likely to be
poorer and live further from the nearest health centre.
Strengths and limitations
We were not able to enrol controls for all the MK cases in
the cohort. However, the sample size was enough to
detect important risk factors and enrolling all the con-
trols may have provided minimal addition. Trauma could
not be tested as risk factors because there was no reported
episode among the controls. Although we were interested
in TEM as a risk factor, it was not feasible to test this: we
could not ascertain whether it had been applied before or
after onset of MK. Before this study, HIV had been
suggested as a potential risk factor. This study provided
strong evidence of HIV as an independent risk factor for
MK, and although the confidence interval is wide, the
estimated effect is large. This was the first case control
design to investigate risk factors of MK in SSA.
Conclusion
HIV, DM, a farming occupation and poverty were
important risk factors for MK in Uganda. There is
need for more work to be done to explore mechanisms
of interaction and how these can inform prevention
strategies against MK. Patients with MK should be
offered HIV and diabetic screening.
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